Indefinite Delivery Contract SPE2DX15D7085
- Not listed
- The federal contract IDV award SPE2DX15D1042 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,999,999.00 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on April 10, 2015, with a performance period through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the prime vendor responsible for delivering a comprehensive range of pharmaceutical...
- The federal contract IDV award SPE2DX16D2905 is a single-award Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $4,999,999.99 contract was awarded on March 2, 2016 by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military...
- The federal contract IDV award SPE2DX16D3925 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The $4,999,999.00 contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as the primary vehicle for...
- The federal contract IDV award SPE2DX15D6912 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,999,999.00 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
- The federal contract IDV award SPE2DX15D5021 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The IDC, valued at up to $999,999,999.00, enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
- The federal contract IDV award, SPE2DX16D3903, is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name...
- The federal contract IDV award, SPE2DX15D1921, is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The federal contract IDV award SPE2DX15D7070 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $4,999,999.00 contract was awarded on April 29, 2015 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and...
- The federal contract IDV award SPE2DX16D2924 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,999,999.99 contract was awarded on June 7, 2016 by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
- The federal contract IDV award SPE2DX15D1043 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a wholly-owned subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a ceiling value of $4,999,999.00 with an ultimate completion date of December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
The federal contract IDV award SPE2DX15D7085 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,999,999.00 contract was awarded on April 29, 2015 by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as the primary vehicle for Amerisourcebergen to provide critical medical commodities to the DLA, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The contract has an ultimate completion date of December 31, 2025 and does not utilize any set-aside requirements, indicating open competition. Additionally, Amerisourcebergen holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024. These comprehensive IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 4/29/15 |